Last month, I shared my top picks – those with stand-out patient popularity – for surgical and non-surgical procedures for 2017. Now, I’m excited to share news of how Capizzi MD has kicked off 2018!
miraDry®
A safe, clinically proven, FDA-cleared answer for significantly reducing underarm sweat – and a recent addition to our practice – miraDry is a simple 60-75 min outpatient non-surgical procedure. If you desire a more natural, toxic-free lifestyle, without the need for antiperspirants, and/or find yourself embarrassed to raise your arms and are continually ruining business shirts or blouses, miraDry is the solution you’ve been waiting for.
Voluma
This tried and true, very popular dermal filler, expertly administered by our nurse injectors, has helped so many of our patients restore suppleness and volume in their cheeks – reversing the decline of midface definition that ages our appearance. What’s new: Recently, Voluma has been found to be highly effective when used to enhance the profile of the chin. As we all age, the jaw line becomes indistinct and less strong, giving the appearance of a “weaker” jaw line. Voluma can add the volume needed to strengthen the jawline.
Sculptra®
Sculptra is an FDA-approved injectable that helps stimulate your skin’s own natural collagen production to help restore its inner structure and increase volume. Typically used for shallow-to-deep facial folds, it can also be injected by our expert staff throughout the buttocks region (usually the mid-to-upper area) to help fill in the dimples and appearance of cellulite. What’s new: We’ve seen increased demand in 2018 for the use of Sculptra for anyone seeking gluteal enhancement.
diVa™ Laser Vaginal Therapy
Introduced to our patients last year, this non-surgical, non-HRT treatment for a host of common vaginal issues including stress incontinence, dryness, difficult intercourse, and tightness of the vaginal canal post-childbirth, yields results after just one seven-minute procedure. What’s new: diVa has taken off in popularity with our patients – and I expect it will continue to do so.